Literature DB >> 22932722

Chances and risks of predicting psychosis.

Stephan Ruhrmann1, Joachim Klosterkötter, Mitja Bodatsch, Alexandra Nikolaides, Dominika Julkowski, Desire Hilboll, Frauke Schultz-Lutter.   

Abstract

Prevention is currently regarded a promising strategy for fighting the unfavorable consequences of psychosis. Yet, for the error probability inherent in any predictive approach, benefits and costs must be carefully weighed against each other. False attribution of risk may unnecessarily provoke stress and anxiety, and lead to unwarranted intervention exposure. However, clinical risk samples already exhibit psychopathological symptoms, cognitive and functional impairments, and help-seeking for mental problems. Thus, the risk of futile interventions is low as long as preventive measures also provide treatment for current complaints. Differentiation between still normal and clinically relevant mental states is another challenge as psychotic-like phenomena occur frequently in the general population, especially in younger adolescents. Reported prevalence rates vary with age, and if severe in terms of frequency and persistence, these phenomena considerably increase risk of psychosis in clinical as well as general population samples. Stigmatization is another concern, though insufficiently studied. Yet, at least more severe states of risk, which are accompanied by changes in thinking, feeling, and behavior, might lead to unfavorable, (self-) stigmatizing effects already by themselves, independent of any diagnostic "label," and to stress and confusion for the lack of understanding of what is going on. To further improve validity of risk criteria, advanced risk algorithms combining multi-step detection and risk stratification procedures should be developed. However, all prediction models possess a certain error probability. Thus, whether a risk model justifies preventive measures can only be decided by weighing the costs of unnecessary intervention and the benefits of avoiding a potentially devastating outcome.

Entities:  

Mesh:

Year:  2012        PMID: 22932722     DOI: 10.1007/s00406-012-0361-4

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  45 in total

1.  Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study.

Authors:  Ian Kelleher; Aileen Murtagh; Charlene Molloy; Sarah Roddy; Mary C Clarke; Michelle Harley; Mary Cannon
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

2.  Recruitment and treatment practices for help-seeking "prodromal" patients.

Authors:  Thomas H McGlashan; Jean Addington; Tyrone Cannon; Markus Heinimaa; Patrick McGorry; Mary O'Brien; David Penn; Diana Perkins; Raimo K R Salokangas; Barbara Walsh; Scott W Woods; Alison Yung
Journal:  Schizophr Bull       Date:  2007-05-04       Impact factor: 9.306

3.  Differential results between self-report and interview-based ratings of risk symptoms of psychosis.

Authors:  Niklas Granö; Marjaana Karjalainen; Arja Itkonen; Jukka Anto; Virve Edlund; Markus Heinimaa; Mikko Roine
Journal:  Early Interv Psychiatry       Date:  2011-05-05       Impact factor: 2.732

4.  Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk".

Authors:  Cheryl Corcoran; Dolores Malaspina; Laura Hercher
Journal:  Schizophr Res       Date:  2005-03-01       Impact factor: 4.939

5.  Burden of care and general health in families of patients with schizophrenia.

Authors:  José Gutiérrez-Maldonado; Alejandra Caqueo-Urízar; David J Kavanagh
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-10-28       Impact factor: 4.328

6.  Strauss (1969) revisited: a psychosis continuum in the general population?

Authors:  J van Os; M Hanssen; R V Bijl; A Ravelli
Journal:  Schizophr Res       Date:  2000-09-29       Impact factor: 4.939

7.  [Costs of early retirement--the case of schizophrenia].

Authors:  Johannes Clouth
Journal:  Psychiatr Prax       Date:  2004-11

8.  Diagnosing schizophrenia in the initial prodromal phase.

Authors:  J Klosterkötter; M Hellmich; E M Steinmeyer; F Schultze-Lutter
Journal:  Arch Gen Psychiatry       Date:  2001-02

9.  The ABC Schizophrenia Study: a preliminary overview of the results.

Authors:  H Häfner; K Maurer; W Löffler; W an der Heiden; P Munk-Jørgensen; M Hambrecht; A Riecher-Rössler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-08       Impact factor: 4.328

Review 10.  A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder.

Authors:  J van Os; R J Linscott; I Myin-Germeys; P Delespaul; L Krabbendam
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

View more
  9 in total

Review 1.  Towards indicated prevention of psychosis: using probabilistic assessments of transition risk in psychosis prodrome.

Authors:  Scott Richard Clark; Klaus Oliver Schubert; Bernhard Theodor Baune
Journal:  J Neural Transm (Vienna)       Date:  2014-10-16       Impact factor: 3.575

2.  Selected issues of the DGPPN Congress in 2011.

Authors:  Andrea Schmitt; Oliver Gruber; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-11       Impact factor: 5.270

3.  Prediction and prevention of psychosis: current progress and future tasks.

Authors:  Stephan Ruhrmann; Frauke Schultze-Lutter; Stefanie J Schmidt; Nathalie Kaiser; Joachim Klosterkötter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-26       Impact factor: 5.270

4.  Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia.

Authors:  Andrea Raballo; Anna Meneghelli; Angelo Cocchi; Davide Sisti; Marco B L Rocchi; Andrea Alpi; Maria T Cascio; Antonio Preti; Kurt Maurer; Heinz Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-09       Impact factor: 5.270

5.  Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers.

Authors:  Nikolaos Koutsouleris; Anita Riecher-Rössler; Eva M Meisenzahl; Renata Smieskova; Erich Studerus; Lana Kambeitz-Ilankovic; Sebastian von Saldern; Carlos Cabral; Maximilian Reiser; Peter Falkai; Stefan Borgwardt
Journal:  Schizophr Bull       Date:  2014-06-09       Impact factor: 9.306

6.  Psychosis prediction: stratification of risk estimation with information-processing and premorbid functioning variables.

Authors:  Dorien H Nieman; Stephan Ruhrmann; Sara Dragt; Francesca Soen; Mirjam J van Tricht; Johannes H T M Koelman; Lo J Bour; Eva Velthorst; Hiske E Becker; Mark Weiser; Don H Linszen; Lieuwe de Haan
Journal:  Schizophr Bull       Date:  2013-10-18       Impact factor: 9.306

Review 7.  Contributions of experimental psychiatry to research on the psychosis prodrome.

Authors:  Mitja Bodatsch; Joachim Klosterkötter; Jörg Daumann
Journal:  Front Psychiatry       Date:  2013-12-17       Impact factor: 4.157

8.  Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) study.

Authors:  Frauke Schultze-Lutter; Chantal Michel; Stephan Ruhrmann; Benno G Schimmelmann
Journal:  Schizophr Bull       Date:  2013-12-18       Impact factor: 9.306

9.  Basic disturbances of information processing in psychosis prediction.

Authors:  Mitja Bodatsch; Joachim Klosterkötter; Ralf Müller; Stephan Ruhrmann
Journal:  Front Psychiatry       Date:  2013-08-23       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.